Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pinelopi Kazakou
Observed name:
Kazakou, P
Institutions:
National and Kapodistrian University of Athens,
University General Hospital Attikon
Observed institutions:
National and Kapodistrian University of Athens,
University General Hospital Attikon,
Sotiria General Hospital
ORCID:
0009-0007-8765-1939
Observed ORCID:
0009-0007-8765-1939
OpenAlex ID:
A5108855042
Association of COVID ‐19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection
2021
·
Vaia Lambadiari
, Asimina Mitrakou
, et al.
·
European Journal of Heart Failure
·
127
PDF
Myocardial work and vascular dysfunction are partially improved at 12 months after COVID ‐19 infection
2022
·
Ignatios Ikonomidis
, Vaia Lambadiari
, et al.
·
European Journal of Heart Failure
·
66
PDF
Successful treatment of life-threatening autoimmune haemolytic anaemia with ofatumumab in a patient with systemic lupus erythematosus
2016
·
Theofanis Karageorgas
, Athanasios Zomas
, et al.
·
Rheumatology
·
14
Real-Life Effectiveness and Safety of Baricitinib as Adjunctive to Standard-of-Care Treatment in Hospitalized Patients With Severe Coronavirus Disease 2019
2021
·
Nikolaos Tziolos
, Emmanouil Karofylakis
, et al.
·
Open Forum Infectious Diseases
·
12
PDF
Remdesivir: Effectiveness and Safety in Hospitalized Patients with COVID-19 (ReEs-COVID-19)—Analysis of Data from Daily Practice
2023
·
Nikos Pantazis
, Evmorfia Pechlivanidou
, et al.
·
Microorganisms
·
9
PDF
Rectal Colonization with Multidrug-Resistant Organisms and Subsequent Bloodstream Infections in Hematological Patients Undergoing Cellular Therapies
2026
·
Pinelopi Kazakou
, Charalampos Charalampidis
, et al.
·
Transplantation and Cellular Therapy
·
4
Comparison of effectiveness and safety between baricitinib and tocilizumab in severe COVID-19: a retrospective study
2025
·
Ioannis Tomos
, Ioannis Grigoropoulos
, et al.
·
Expert Review of Respiratory Medicine
·
2
Breakthrough COVID-19 Infections after Booster SARS-CoV-2 Vaccination in a Greek Cohort of People Living with HIV during the Delta and Omicron Waves
2024
·
Konstantinos Protopapas
, Konstantinos Thomas
, et al.
·
Biomedicines
·
2
Rectal carriage with carbapenem-resistant organisms, vancomycin-resistant enterococci, and Clostridioides difficile: insights from a point-prevalence survey in a high-endemic setting
2026
·
Polyxeni Karakosta
, Eleni Kalogeropoulou
, et al.
·
Diagnostic Microbiology and Infectious Disease
·
1
PDF
Remdesivir: Effectiveness and Safety in Hospitalized COVID-19 Patients—Analysis of Retrospectively Collected Data from Daily Practice in the Omicron Variant Era and Comparison with the Pre-Omicron Period
2025
·
Nikos Pantazis
, Evmorfia Pechlivanidou
, et al.
·
Microorganisms
·
1
PDF
Longitudinal evaluation of a multidisciplinary infection prevention and control bundle in a high AMR prevalence ICU
2026
·
Polyxeni Karakosta
, Frantzeska Frantzeskaki
, et al.
·
American Journal of Infection Control
Remdesivir: Real-World Effectiveness and Safety in Individuals Hospitalized for Non-COVID Reasons and Non-Hospitalized High-Risk Patients During the Omicron Era in Greece
2026
·
Nikos Pantazis
, Spyridon Kontos
, et al.
·
Microorganisms
PDF
MUC5B polymorphism and post COVID-19 lung abnormalities on chest CT-scan
2025
·
Celestie Yaacoub
, Coralie Tardivon
, et al.
·
Respiratory Medicine and Research
A two-year Prospective Study on Hospital-Acquired Bacteremias caused by Multidrug-Resistant Organisms in a High-Prevalence Country
2025
·
Grigoropoulou, S
, Tsakona, M
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
COVID-19: the day after
2021
·
Elvira Markela Antonogiannaki
, Konstantinos Thomas
, et al.
·
European Respiratory Journal
Show more works
View as search
Works count:
15
Citation count:
238
H-index:
5
I10-index:
4
Year
Topic
Type